KEGG   PATHWAY: hsa04630
hsa04630                    Pathway                                
JAK-STAT signaling pathway - Homo sapiens (human)
The Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway is one of a handful of pleiotropic cascades used to transduce a multitude of signals for development and homeostasis in animals, from humans to flies. In mammals, the JAK/STAT pathway is the principal signaling mechanism for a wide array of cytokines and growth factors. Following the binding of cytokines to their cognate receptor, STATs are activated by members of the JAK family of tyrosine kinases. Once activated, they dimerize and translocate to the nucleus and modulate the expression of target genes. In addition to the activation of STATs, JAKs mediate the recruitment of other molecules such as the MAP kinases, PI3 kinase etc. These molecules process downstream signals via the Ras-Raf-MAP kinase and PI3 kinase pathways which results in the activation of additional transcription factors.
Environmental Information Processing; Signal transduction
Pathway map
hsa04630  JAK-STAT signaling pathway

N00053  Cytokine-Jak-STAT signaling pathway
N00094  EGF-Jak-STAT signaling pathway
N00415  IL10 family to Jak-STAT signaling pathway
N01554  IL2 family to Jak-STAT signaling pathway
N01555  Hormone-like-cytokine to Jak-STAT signaling pathway
N01556  IL6 family to Jak-STAT signaling pathway
N01557  IL12/23 to Jak-STAT signaling pathway
N01558  Type I interferon to Jak-STAT signaling pathway
N01559  Type II interferon to Jak-STAT signaling pathway
N01804  IL3 family to Jak-STAT signaling pathway
D00745  Interferon alfa-2a (USAN/INN)
D00746  Interferon beta-1b (USAN/INN)
D00747  Interferon gamma-1b (USAN/INN)
D00748  Aldesleukin (USAN/INN)
D02596  Tocilizumab (USAN/INN)
D02743  Celmoleukin (genetical recombination) (JP18)
D02744  Interferon alfacon-1 (USAN/INN)
D02745  Interferon alfa-2b (USAN)
D02747  Peginterferon alfa-2a (USAN/INN)
D02748  Peginterferon alfa-2b (USAN/INN)
D02749  Teceleukin (USAN)
D03058  Basiliximab (USAN/INN)
D03117  Binetrakin (USAN/INN)
D03231  Epoetin alfa (USAN/INN)
D03232  Epoetin beta (USAN/INN)
D03235  Filgrastim (USP/INN)
D03245  Nartograstim (genetical recombination) (JP18)
D03247  Lenograstim (USAN/INN)
D03304  Interferon beta (JAN)
D03305  Interferon alfa (NAMALWA) (JP18)
D03357  Interferon gamma-1a (genetical recombination) (JAN)
D03639  Daclizumab (USAN/INN)
D03645  Daniplestim (USAN/INN)
D03647  Dapiclermin (USAN/INN)
D03651  Darbepoetin alfa (USAN/INN)
D03682  Denileukin diftitox (USAN/INN)
D03978  Eltrombopag olamine (JAN/USAN)
D04032  Epoetin delta (USAN)
D04552  Interferon alfa-n1 (USAN)
D04553  Interferon alfa-n3 (USAN)
D04554  Interferon beta-1a (USAN)
D04695  Leridistim (USAN/INN)
D04923  Mepolizumab (USAN/INN)
D05036  Milodistim (USAN/INN)
D05066  Molgramostim (USAN/INN)
D05090  Muplestim (USAN/INN)
D05266  Oprelvekin (USAN/INN)
D05377  Pascolizumab (USAN/INN)
D05389  Pegnartograstim (USAN/INN)
D05803  Sargramostim (USP/INN)
D06556  Apilimod mesylate (USAN)
D06889  Pegfilgrastim (USAN/INN)
D08805  Interferon gamma-n1 (JAN)
D08844  Albinterferon alfa-2b (USAN)
D08985  Reslizumab (USAN)
D08990  Romiplostim (USAN/INN)
D09024  Totrombopag choline (USAN)
D09214  Ustekinumab (USAN/INN)
D09332  Denenicokin (USAN/INN)
D09588  Briakinumab (USAN/INN)
D09633  Lebrikizumab (USAN/INN)
D09669  Siltuximab (USAN/INN)
D09783  Tofacitinib citrate (JAN/USAN)
D09897  Enokizumab (USAN/INN)
D09930  Mavrilimumab (USAN/INN)
D09946  Peginesatide (USAN/INN)
D09947  Peginesatide acetate (JAN/USAN)
D09959  Ruxolitinib (USAN/INN)
D09960  Ruxolitinib phosphate (JAN/USAN)
D09970  Tofacitinib (USAN)
D09979  Tralokinumab (USAN/INN)
D09998  Epoetin beta pegol (genetical recombination) (JAN)
D10000  Epoetin epsilon (INN)
D10015  Litgenprostucel-L (USAN)
D10078  Peginterferon lambda-1a (USAN)
D10080  Sirukumab (USAN)
D10161  Sarilumab (USAN)
D10242  Lipegfilgrastim (USAN)
D10306  Avatrombopag (USAN/INN)
D10307  Avatrombopag maleate (JAN/USAN)
D10308  Baricitinib (JAN/USAN/INN)
D10310  Balugrastim (USAN/INN)
D10354  Dupilumab (USAN/INN)
D10365  Gandotinib (USAN/INN)
D10438  Guselkumab (USAN/INN)
D10476  Lusutrombopag (JAN/USAN/INN)
D10483  Peginterferon beta-1a (USAN/INN)
D10630  Fedratinib (USAN/INN)
D10717  Napabucasin (JAN/USAN/INN)
D10846  Epoetin theta (INN)
D10847  Epoetin zeta (INN)
D10871  Filgotinib (USAN/INN)
D10872  Filgotinib hydrochloride (USAN)
D10889  Momelotinib hydrochloride hydrate (JAN)
D10944  Itacitinib (USAN/INN)
D10945  Itacitinib adipate (JAN/USAN)
D10994  Upadacitinib (USAN/INN)
D10995  Upadacitinib tartrate (USAN)
D11026  Pegteograstim (INN)
D11027  Ropeginterferon alfa-2b (INN)
D11046  Delgocitinib (JAN/USAN/INN)
D11048  Upadacitinib hydrate (JAN)
D11052  Risankizumab (USAN/INN)
D11079  Satralizumab (USAN/INN)
D11106  Filgotinib maleate (JAN/USAN)
D11123  Mirikizumab (USAN/INN)
D11188  Eflapegrastim (USAN/INN)
D11193  Somavaratan (USAN/INN)
D11200  Pegilodecakin (USAN/INN)
D11296  Fedratinib hydrochloride (USAN)
D11400  Abrocitinib (JAN/USAN)
D11537  Brepocitinib (USAN)
D11538  Brepocitinib tosylate (USAN)
D11598  Romilkimab (USAN/INN)
D11676  Gusacitinib (USAN/INN)
D11677  Gusacitinib hydrochloride (USAN)
D11747  Inbakicept (USAN/INN)
D11756  Fletikumab (USAN/INN)
D11771  Tezepelumab (USAN/INN)
D11800  Vixarelimab (USAN)
D11817  Deucravacitinib (JAN/USAN)
D11821  Nogapendekin alfa (USAN/INN)
D11866  Deuruxolitinib (USAN)
D11867  Deuruxolitinib phosphate (USAN)
D11953  Efmarodocokin alfa (USAN/INN)
D11962  Murizatoclax (USAN/INN)
D11963  Tapotoclax (USAN/INN)
D11970  Ritlecitinib tosylate (USAN)
D11986  Efbemalenograstim alfa (USAN/INN)
D12056  Ropsacitinib (USAN)
D12118  Nezulcitinib (USAN)
D12169  Depemokimab (USAN)
D12211  Ivarmacitinib (USAN)
D12212  Ivarmacitinib sulfate (USAN)
D12306  Ordesekimab (USAN)
D12307  Pivekimab (USAN)
D12308  Pivekimab sunirine (USAN)
D12328  Rezpegaldesleukin (USAN)
D12371  Nemvaleukin alfa (USAN/INN)
D12386  Melredableukin alfa (USAN/INN)
D12479  Lusvertikimab (USAN/INN)
D12487  Olokizumab (INN)
D12502  Golidocitinib (USAN/INN)
D12575  Povorcitinib (USAN/INN)
D12576  Povorcitinib phosphate (USAN)
D12623  Nanrilkefusp alfa (USAN/INN)
D12625  Pegenzileukin (USAN/INN)
D12709  Dalmitamig (USAN)
D12725  Lomedeucitinib (USAN)
D12731  Anumigilimab (USAN/INN)
D12739  Bempikibart (USAN/INN)
D12748  Levilimab (INN)
D12784  Casdozokitug (USAN/INN)
D12786  Lepzacitinib (USAN)
D12807  Ziltivekimab (USAN/INN)
D12810  Falbikitug (USAN/INN)
D12815  Eltrombopag choline
D12824  Temtokibart (USAN/INN)
D12850  Imneskibart (USAN)
D12888  Nogapendekin alfa inbakicept
D12928  Vopikitug (USAN/INN)
D12929  Vamikibart (USAN/INN)
Other DBs
GO: 0007259
Homo sapiens (human) [GN:hsa]
3558  IL2; interleukin 2 [KO:K05429]
3565  IL4; interleukin 4 [KO:K05430]
3574  IL7; interleukin 7 [KO:K05431]
3578  IL9; interleukin 9 [KO:K05432]
3600  IL15; interleukin 15 [KO:K05433]
59067  IL21; interleukin 21 [KO:K05434]
85480  TSLP; thymic stromal lymphopoietin [KO:K05436]
3559  IL2RA; interleukin 2 receptor subunit alpha [KO:K05068]
3560  IL2RB; interleukin 2 receptor subunit beta [KO:K05069]
3561  IL2RG; interleukin 2 receptor subunit gamma [KO:K05070]
3566  IL4R; interleukin 4 receptor [KO:K05071]
3575  IL7R; interleukin 7 receptor [KO:K05072]
3581  IL9R; interleukin 9 receptor [KO:K05073]
3601  IL15RA; interleukin 15 receptor subunit alpha [KO:K05074]
50615  IL21R; interleukin 21 receptor [KO:K05075]
64109  CRLF2; cytokine receptor like factor 2 [KO:K05078]
3562  IL3; interleukin 3 [KO:K04736]
3567  IL5; interleukin 5 [KO:K05428]
1437  CSF2; colony stimulating factor 2 [KO:K05427]
3563  IL3RA; interleukin 3 receptor subunit alpha [KO:K04737]
3568  IL5RA; interleukin 5 receptor subunit alpha [KO:K05067]
1438  CSF2RA; colony stimulating factor 2 receptor subunit alpha [KO:K05066]
1439  CSF2RB; colony stimulating factor 2 receptor subunit beta [KO:K04738]
3569  IL6; interleukin 6 [KO:K05405]
3589  IL11; interleukin 11 [KO:K05417]
3596  IL13; interleukin 13 [KO:K05435]
246778  IL27; interleukin 27 [KO:K22629]
386653  IL31; interleukin 31 [KO:K22631]
5008  OSM; oncostatin M [KO:K05418]
3976  LIF; LIF interleukin 6 family cytokine [KO:K05419]
1270  CNTF; ciliary neurotrophic factor [KO:K05420]
1489  CTF1; cardiotrophin 1 [KO:K05422]
23529  CLCF1; cardiotrophin like cytokine factor 1 [KO:K05421]
3570  IL6R; interleukin 6 receptor [KO:K05055]
3572  IL6ST; interleukin 6 cytokine family signal transducer [KO:K05060]
3590  IL11RA; interleukin 11 receptor subunit alpha [KO:K05056]
3597  IL13RA1; interleukin 13 receptor subunit alpha 1 [KO:K05076]
3598  IL13RA2; interleukin 13 receptor subunit alpha 2 [KO:K05077]
9466  IL27RA; interleukin 27 receptor subunit alpha [KO:K19598]
133396  IL31RA; interleukin 31 receptor A [KO:K22630]
9180  OSMR; oncostatin M receptor [KO:K05057]
3977  LIFR; LIF receptor subunit alpha [KO:K05058]
1271  CNTFR; ciliary neurotrophic factor receptor [KO:K05059]
3586  IL10; interleukin 10 [KO:K05443]
29949  IL19; interleukin 19 [KO:K05444]
50616  IL22; interleukin 22 [KO:K05445]
50604  IL20; interleukin 20 [KO:K22667]
11009  IL24; interleukin 24 [KO:K22668]
55801  IL26; interleukin 26 [KO:K05446]
3587  IL10RA; interleukin 10 receptor subunit alpha [KO:K05134]
3588  IL10RB; interleukin 10 receptor subunit beta [KO:K05135]
53832  IL20RA; interleukin 20 receptor subunit alpha [KO:K05136]
53833  IL20RB; interleukin 20 receptor subunit beta [KO:K05137]
58985  IL22RA1; interleukin 22 receptor subunit alpha 1 [KO:K05138]
116379  IL22RA2; interleukin 22 receptor subunit alpha 2 [KO:K05139]
3592  IL12A; interleukin 12A [KO:K05406]
3593  IL12B; interleukin 12B [KO:K05425]
51561  IL23A; interleukin 23 subunit alpha [KO:K05426]
3594  IL12RB1; interleukin 12 receptor subunit beta 1 [KO:K05063]
3595  IL12RB2; interleukin 12 receptor subunit beta 2 [KO:K05064]
149233  IL23R; interleukin 23 receptor [KO:K05065]
2056  EPO; erythropoietin [KO:K05437]
2688  GH1; growth hormone 1 [KO:K05438]
2689  GH2; growth hormone 2 [KO:K05438]
1442  CSH1; chorionic somatomammotropin hormone 1 [KO:K05438]
1443  CSH2; chorionic somatomammotropin hormone 2 [KO:K05438]
1444  CSHL1; chorionic somatomammotropin hormone like 1 [KO:K05438]
5617  PRL; prolactin [KO:K05439]
7066  THPO; thrombopoietin [KO:K06854]
1440  CSF3; colony stimulating factor 3 [KO:K05423]
3952  LEP; leptin [KO:K05424]
2057  EPOR; erythropoietin receptor [KO:K05079]
2690  GHR; growth hormone receptor [KO:K05080]
5618  PRLR; prolactin receptor [KO:K05081]
4352  MPL; MPL proto-oncogene, thrombopoietin receptor [KO:K05082]
1441  CSF3R; colony stimulating factor 3 receptor [KO:K05061]
3953  LEPR; leptin receptor [KO:K05062]
3439  IFNA1; interferon alpha 1 [KO:K05414]
3440  IFNA2; interferon alpha 2 [KO:K05414]
3441  IFNA4; interferon alpha 4 [KO:K05414]
3442  IFNA5; interferon alpha 5 [KO:K05414]
3443  IFNA6; interferon alpha 6 [KO:K05414]
3444  IFNA7; interferon alpha 7 [KO:K05414]
3445  IFNA8; interferon alpha 8 [KO:K05414]
3446  IFNA10; interferon alpha 10 [KO:K05414]
3447  IFNA13; interferon alpha 13 [KO:K05414]
3448  IFNA14; interferon alpha 14 [KO:K05414]
3449  IFNA16; interferon alpha 16 [KO:K05414]
3451  IFNA17; interferon alpha 17 [KO:K05414]
3452  IFNA21; interferon alpha 21 [KO:K05414]
3456  IFNB1; interferon beta 1 [KO:K05415]
338376  IFNE; interferon epsilon [KO:K05442]
56832  IFNK; interferon kappa [KO:K05441]
282618  IFNL1; interferon lambda 1 [KO:K05447]
282616  IFNL2; interferon lambda 2 [KO:K22669]
282617  IFNL3; interferon lambda 3 [KO:K22669]
3467  IFNW1; interferon omega 1 [KO:K05440]
3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]
3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]
163702  IFNLR1; interferon lambda receptor 1 [KO:K05140]
3458  IFNG; interferon gamma [KO:K04687]
3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]
3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]
1950  EGF; epidermal growth factor [KO:K04357]
5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]
5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]
1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:]
5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:]
5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:]
3716  JAK1; Janus kinase 1 [KO:K11217] [EC:]
3717  JAK2; Janus kinase 2 [KO:K04447] [EC:]
3718  JAK3; Janus kinase 3 [KO:K11218] [EC:]
7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:]
6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]
6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]
6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]
6775  STAT4; signal transducer and activator of transcription 4 [KO:K11222]
6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]
6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]
6778  STAT6; signal transducer and activator of transcription 6 [KO:K11225]
10379  IRF9; interferon regulatory factor 9 [KO:K04693]
1154  CISH; cytokine inducible SH2 containing protein [KO:K04701]
8651  SOCS1; suppressor of cytokine signaling 1 [KO:K04694]
8835  SOCS2; suppressor of cytokine signaling 2 [KO:K04695]
9021  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]
122809  SOCS4; suppressor of cytokine signaling 4 [KO:K04697]
9655  SOCS5; suppressor of cytokine signaling 5 [KO:K04698]
30837  SOCS7; suppressor of cytokine signaling 7 [KO:K04699]
9306  SOCS6; suppressor of cytokine signaling 6 [KO:K04699]
596  BCL2; BCL2 apoptosis regulator [KO:K02161]
4170  MCL1; MCL1 apoptosis regulator, BCL2 family member [KO:K02539]
598  BCL2L1; BCL2 like 1 [KO:K04570]
5292  PIM1; Pim-1 proto-oncogene, serine/threonine kinase [KO:K04702] [EC:]
4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]
595  CCND1; cyclin D1 [KO:K04503]
894  CCND2; cyclin D2 [KO:K10151]
896  CCND3; cyclin D3 [KO:K10152]
1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]
316  AOX1; aldehyde oxidase 1 [KO:K00157] [EC:]
2670  GFAP; glial fibrillary acidic protein [KO:K05640]
10254  STAM2; signal transducing adaptor molecule 2 [KO:K04705]
8027  STAM; signal transducing adaptor molecule [KO:K04705]
5771  PTPN2; protein tyrosine phosphatase non-receptor type 2 [KO:K18026] [EC:]
5777  PTPN6; protein tyrosine phosphatase non-receptor type 6 [KO:K05697] [EC:]
1387  CREBBP; CREB binding protein [KO:K04498] [EC:]
2033  EP300; E1A binding protein p300 [KO:K04498] [EC:]
8554  PIAS1; protein inhibitor of activated STAT 1 [KO:K04706] [EC:2.3.2.-]
9063  PIAS2; protein inhibitor of activated STAT 2 [KO:K16063] [EC:2.3.2.-]
10401  PIAS3; protein inhibitor of activated STAT 3 [KO:K16064] [EC:2.3.2.-]
51588  PIAS4; protein inhibitor of activated STAT 4 [KO:K16065] [EC:]
2273  FHL1; four and a half LIM domains 1 [KO:K14365]
5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:]
2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]
6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]
6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]
3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]
5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:]
5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:]
5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:]
5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:]
5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
110117499  P3R3URF-PIK3R3; P3R3URF-PIK3R3 readthrough [KO:K02649]
207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:]
208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:]
10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:]
2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:]
Harrison DA
The Jak/STAT pathway.
Cold Spring Harb Perspect Biol 4:a011205 (2012)
Kiu H, Nicholson SE
Biology and significance of the JAK/STAT signalling pathways.
Growth Factors 30:88-106 (2012)
Hervas-Stubbs S, Perez-Gracia JL, Rouzaut A, Sanmamed MF, Le Bon A, Melero I
Direct effects of type I interferons on cells of the immune system.
Clin Cancer Res 17:2619-27 (2011)
Fish EN, Platanias LC
Interferon receptor signaling in malignancy: a network of cellular pathways defining biological outcomes.
Mol Cancer Res 12:1691-703 (2014)
Ivanenkov YA, Balakin KV, Lavrovsky Y
Small molecule inhibitors of NF-kB and JAK/STAT signal transduction pathways as promising anti-inflammatory therapeutics.
Mini Rev Med Chem 11:55-78 (2011)
O'Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A
The JAK-STAT pathway: impact on human disease and therapeutic intervention.
Annu Rev Med 66:311-28 (2015)
Zoranovic T, Grmai L, Bach EA
Regulation of proliferation, cell competition, and cellular growth by the Drosophila JAK-STAT pathway.
JAKSTAT 2:e25408 (2013)
Ungureanu D, Silvennoinen O
SLIM trims STATs: ubiquitin E3 ligases provide insights for specificity in the regulation of cytokine signaling.
Sci STKE 2005:pe49 (2005)
Richard AJ, Stephens JM
The role of JAK-STAT signaling in adipose tissue function.
Biochim Biophys Acta 1842:431-9 (2014)
Sun Y, Lehmbecker A, Kalkuhl A, Deschl U, Sun W, Rohn K, Tzvetanova ID, Nave KA, Baumgartner W, Ulrich R
STAT3 represents a molecular switch possibly inducing astroglial instead of oligodendroglial differentiation of oligodendroglial progenitor cells in Theiler's murine encephalomyelitis.
Neuropathol Appl Neurobiol 41:347-70 (2015)
Hirano T, Ishihara K, Hibi M
Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
Oncogene 19:2548-56 (2000)
Rane SG, Reddy EP
Janus kinases: components of multiple signaling pathways.
Oncogene 19:5662-79 (2000)
Heim MH
The Jak-STAT pathway: specific signal transduction from the cell membrane to the nucleus.
Eur J Clin Invest 26:1-12 (1996)
Morris R, Kershaw NJ, Babon JJ
The molecular details of cytokine signaling via the JAK/STAT pathway.
Protein Sci 27:1984-2009 (2018)
Tzeng HT, Chyuan IT, Lai JH
Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential.
Biochem Pharmacol 193:114760 (2021)
Salas A, Hernandez-Rocha C, Duijvestein M, Faubion W, McGovern D, Vermeire S, Vetrano S, Vande Casteele N
JAK-STAT pathway targeting for the treatment of inflammatory bowel disease.
Nat Rev Gastroenterol Hepatol 17:323-337 (2020)
hsa04010  MAPK signaling pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04110  Cell cycle
hsa04120  Ubiquitin mediated proteolysis
hsa04151  PI3K-Akt signaling pathway
hsa04210  Apoptosis
KO pathway

DBGET integrated database retrieval system